• International
  • Albania
  • Bosnia and Herzegovina
  • Bulgaria
  • Croatia
  • Czech Republic
  • Estonia
  • Hungary
  • Latvia
  • Lithuania
  • Kosovo
  • North Macedonia
  • Poland
  • Romania
  • Serbia
  • Slovakia
  • Slovenia
  • Switzerland (German)
  • Switzerland (French)
  • Media
  • Meet us
  • Careers
  • Contact
ewopharma
  • Business Development
    • Licensing
    • Strategic Therapeutic Areas
    • Territory
  • Partners & Brands
    • Testimonials
  • About Ewopharma
    • Vision/Mission
    • Our Values
    • Our Strategy
    • Leadership
    • Corporate Responsibility
    • Territory
  • Media
  • Meet us
  • Careers
  • Contact
  • International
  • Albania
  • Bosnia and Herzegovina
  • Bulgaria
  • Croatia
  • Czech Republic
  • Estonia
  • Hungary
  • Latvia
  • Lithuania
  • Kosovo
  • North Macedonia
  • Poland
  • Romania
  • Serbia
  • Slovakia
  • Slovenia
  • Switzerland (German)
  • Switzerland (French)
 

Media

Our Logo

Download Logo

CONTACT

Ewopharma AG
Vordergasse 43
8200 Schaffhausen
Switzerland

Tel.: +41 52 633 09 99
E-Mail: pr@remove-this.ewopharma.com

PRESS RELEASES

  • 1
  • 2
  • 3
  • Next
29.04.2022

Calmino and Ewopharma join up to treat Irritable Bowel Syndrome (IBS)

Read more
17.05.2021

Neobiomics AB and Ewopharma AG announce an exclusive collaboration for distribution of ProPrems® in Switzerland

Read more
16.03.2021

Can-Fite Signs $42.7 Million Out-Licensing Deal with Ewopharma

Read more
23.10.2020

Acar’Up and Ewopharma join the fight against dust mite allergy by launching ExAller®

Read more
26.03.2020

Ewopharma and Eisai announce Commercial Partnership in Central Eastern Europe for Lenvima® (lenvatinib)

Read more
  • 1
  • 2
  • 3
  • Next

Ewopharma AG
Vordergasse 43
8200 Schaffhausen
Switzerland

CONTACT

Phone: +41 52 633 09 99
E-mail:  info@remove-this.ewopharma.com

  • Privacy Policy
  • Cookie Policy
  • Imprint
  • VPOIS

© Copyright 2022, Ewopharma AG